KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Work In Process (2016 - 2025)

Historic Work In Process for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to $210.9 million.

  • Charles River Laboratories International's Work In Process fell 428.46% to $210.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $210.9 million, marking a year-over-year decrease of 428.46%. This contributed to the annual value of $212.0 million for FY2024, which is 701.75% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Work In Process stood at $210.9 million, which was down 428.46% from $215.2 million recorded in Q2 2025.
  • Charles River Laboratories International's Work In Process' 5-year high stood at $228.5 million during Q3 2023, with a 5-year trough of $154.0 million in Q1 2021.
  • For the 5-year period, Charles River Laboratories International's Work In Process averaged around $202.6 million, with its median value being $212.0 million (2024).
  • Its Work In Process has fluctuated over the past 5 years, first surged by 2821.66% in 2021, then tumbled by 701.75% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Work In Process (Quarter) stood at $160.6 million in 2021, then increased by 27.02% to $204.0 million in 2022, then grew by 11.76% to $228.0 million in 2023, then dropped by 7.02% to $212.0 million in 2024, then fell by 0.53% to $210.9 million in 2025.
  • Its Work In Process was $210.9 million in Q3 2025, compared to $215.2 million in Q2 2025 and $216.0 million in Q1 2025.